Copyright
©The Author(s) 2018.
World J Clin Cases. May 16, 2018; 6(5): 74-83
Published online May 16, 2018. doi: 10.12998/wjcc.v6.i5.74
Published online May 16, 2018. doi: 10.12998/wjcc.v6.i5.74
Figure 1 Kaplan-Meier survival cure for the sorafenib plus transarterial chemoembolization and the transarterial chemoembolization alone group.
- Citation: Lei XF, Ke Y, Bao TH, Tang HR, Wu XS, Shi ZT, Lin J, Zhang ZX, Gu H, Wang L. Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study. World J Clin Cases 2018; 6(5): 74-83
- URL: https://www.wjgnet.com/2307-8960/full/v6/i5/74.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v6.i5.74